Skip to main content

Advertisement

Log in

Determining whether postoperative chemoradiotherapy is required in patients with pathologic T3N0 rectal cancer with negative resection margin

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

This study aimed to identify the risk factors for locoregional recurrence (LR) and determine possible candidates for postoperative concurrent chemoradiotherapy (CCRT) in pathologic T3N0 (pT3N0) rectal cancer patients with a negative resection margin after total mesorectal excision (TME).

Method

Data from 365 patients who had pT3N0 rectal cancer between 2003 and 2012 in the Samsung Medical Center were reviewed. All patients underwent upfront surgery without preoperative treatment. Postoperative management involved either no adjuvant therapy (n = 122), chemotherapy alone (n = 100), or CCRT (n = 143).

Results

The median follow-up duration was 71 months. The 5-year overall survival, disease-free survival, and LR-free survival (LRFS) rates were 95.9%, 86.9%, and 96.3%, respectively. When comparing the three groups (surgery alone [n = 122], chemotherapy alone [n = 100], and CCRT [n = 143]), there was no significant difference in LRFS among them (94.0%, 93.4%, and 99.2%, respectively; p = 0.20). However, when patients were stratified by risk factors (distance from anal verge ≤ 5 cm and distal resection margin [DRM] ≤ 2 cm), the 5-year LRFS improved by more than 10% by adding CCRT (98.9% with CCRT vs. 87.4% without CCRT, p = 0.006) in those with more than one risk factor. Postoperative CCRT did not affect the 5-year LRFS (100% with CCRT vs. 99.0% without CCRT, p = 0.66) in patients with no risk factors.

Conclusion

Postoperative CCRT significantly decreased LR in patients with pT3N0 rectal cancer with a negative resection margin but having a distance from the anal verge ≤ 5 cm or DRM ≤ 2 cm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66:683–691

    Article  PubMed  Google Scholar 

  2. Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rodel C, Cervantes A, Arnold D, Committee EG (2017) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:iv22–iv40

    Article  CAS  PubMed  Google Scholar 

  3. Mendenhall WM, Million RR, Pfaff WW (1983) Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: implications in treatment planning with adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 9:977–985

    Article  CAS  PubMed  Google Scholar 

  4. Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G (1983) Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 52:1317–1329

    Article  CAS  PubMed  Google Scholar 

  5. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC, Mailliard JA, Twito DI, Morton RF, Veeder MH, Witzig TE, Cha S, Vidyarthi SC (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709–715

    Article  CAS  PubMed  Google Scholar 

  6. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study G (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740

    Article  CAS  PubMed  Google Scholar 

  7. Enker WE, Thaler HT, Cranor ML, Polyak T (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335–346

    CAS  PubMed  Google Scholar 

  8. Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482

    Article  CAS  PubMed  Google Scholar 

  9. Picon AI, Moore HG, Sternberg SS, Minsky BD, Paty PB, Blumberg D, Quan SH, Wong WD, Cohen AM, Guillem JG (2003) Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis 18:487–492

    Article  PubMed  Google Scholar 

  10. Nissan A, Stojadinovic A, Shia J, Hoos A, Guillem JG, Klimstra D, Cohen AM, Minsky BD, Paty PB, Wong WD (2006) Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol 24:4078–4084

    Article  PubMed  Google Scholar 

  11. Xiao WW, Zhang LN, You KY, Huang R, Yu X, Chang H, Ding PR, Gao YH (2018) The total number of lymph nodes harvested from pathological T3N0 rectal cancer patients: prognostic significance and potential indication for postoperative radiotherapy. J Cancer Res Ther 14:S288–S294

    Article  PubMed  Google Scholar 

  12. Lai LL, Fuller CD, Kachnic LA, Thomas CR Jr (2006) Can pelvic radiotherapy be omitted in select patients with rectal cancer? Semin Oncol 33:S70–S74

    Article  PubMed  Google Scholar 

  13. Merchant NB, Guillem JG, Paty PB, Enker WE, Minsky BD, Quan SH, Wong D, Cohen AM (1999) T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg 3:642–647

    Article  CAS  PubMed  Google Scholar 

  14. Willett CG, Badizadegan K, Ancukiewicz M, Shellito PC (1999) Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 42:167–173

    Article  CAS  PubMed  Google Scholar 

  15. Wo JY, Mamon HJ, Ryan DP, Hong TS (2011) T3N0 rectal cancer: radiation for all? Semin Radiat Oncol 21:212–219

    Article  PubMed  Google Scholar 

  16. MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, Mehta AC, Ohno Y, Powell CA, Prokop M, Rubin GD, Schaefer-Prokop CM, Travis WD, Van Schil PE, Bankier AA (2017) Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society. Radiology 284:228–243

    Article  PubMed  Google Scholar 

  17. Gunderson LL, Callister M, Marschke R, Young-Fadok T, Heppell J, Efron J (2008) Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status. Gastrointest Cancer Res 2:25–33

    PubMed  PubMed Central  Google Scholar 

  18. Wu JX, Wang Y, Chen N, Chen LC, Bai PG, Pan JJ (2014) In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer. Radiat Oncol 9:159

    Article  PubMed  PubMed Central  Google Scholar 

  19. Eriksen MT, Wibe A, Haffner J, Wiig JN, Norwegian Rectal Cancer G (2007) Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 50:156–167

    Article  PubMed  Google Scholar 

  20. Zhu J, Xu Y, Gu W, Peng J, Cai G, Cai G, Sun W, Shen W, Cai S, Zhang Z (2010) Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients. Radiat Oncol 5:118

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kim JH (2017) Controversial issues in radiotherapy for rectal cancer: a systematic review. Radiat Oncol J 35:295–305

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Baek JY, Yu JI, Park HC, Choi DH, Yoo GS, Cho WK, Lee WY, Yun SH, Cho YB, Park YA, Kim HC (2019) Risk factors for locoregional recurrence in patients with pathologic T3N0 rectal cancer with negative resection margin treated by surgery alone. Radiat Oncol J 37:110–116

    Article  PubMed  PubMed Central  Google Scholar 

  23. Park IJ, Kim HC, Yu CS, Kim TW, Jang SJ, Kim JC (2008) Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer. Ann Surg Oncol 15:519–525

    Article  PubMed  Google Scholar 

  24. Kennecke H, Lim H, Woods R, McGahan CE, Hay J, Raval MJ, Johal B (2012) Outcomes of unselected patients with pathologic T3N0 rectal cancer. Radiother Oncol 105:214–219

    Article  PubMed  Google Scholar 

  25. Kim JH, Lee JY, Kim HK, Lee JW, Jung SG, Jung K, Kim SE, Moon W, Park MI, Park SJ (2017) Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer. World J Gastroenterol 23:505–515

    Article  PubMed  PubMed Central  Google Scholar 

  26. Pine JK, Morris E, Hutchins GG, West NP, Jayne DG, Quirke P, Prasad KR (2015) Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour. Br J Cancer 113:204–211

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2017R1D1A1B03031275).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jeong Il Yu or Hee Chul Park.

Ethics declarations

The present study was approved and exempted from requiring participant consent by the Samsung Medical Center institutional review board (IRB No. 2019-08-071).

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 591 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baek, J.Y., Yu, J.I., Park, H.C. et al. Determining whether postoperative chemoradiotherapy is required in patients with pathologic T3N0 rectal cancer with negative resection margin. Int J Colorectal Dis 35, 2239–2248 (2020). https://doi.org/10.1007/s00384-020-03701-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-020-03701-z

Keywords

Navigation